当前位置: 首页 > 详情页

Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits alpha-synuclein aggregation in hippocampus and striatum in aged mice

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China
出处:
ISSN:

关键词: Tetrahydroxystilbene glucoside memory ability movement function synapse alpha-synuclein hippocampus striatum aging

摘要:
Purpose: To investigate the effects of 2,3,5,4 alpha-tetrahydroxystilbene-2-O-beta-D-glucoside (TSG) on the memory and movement functions and its mechanisms related to synapses and alpha-synuclein in aged mice. Methods: The memory ability of mice was detected by step-through passive avoidance task. The movement function was measured by the pole test and rotarod test. Transmission electron microscopy was used to observe the synaptic ultrastructure. Western blotting was applied to measure the expression of synapse-related proteins and alpha-synuclein. Results: Intragastrical administration of TSG for 3 months significantly improved the memory and movement functions in aged mice. TSG treatment obviously protected the synaptic ultrastructure and increased the number of synaptic connections in the hippocampal CA1 region and striatum; enhanced the expression of synaptophysin, phosphorylated synapsin I and postsynaptic density protein 95 (PSD95), elevated phosphorylated calcium/calmodulin-dependent protein kinase II (p-CaMKII) expression, and inhibited the overexpression and aggregation of alpha-synuclein in the hippocampus, striatum and cerebral cortex of aged mice. Conclusion: TSG improved the memory and movement functions in aged mice through protecting synapses and inhibiting alpha-synuclein overexpression and aggregation in multiple brain regions. The results suggest that TSG may be beneficial to the treatment of ageing-related neurodegenerative diseases.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 3 区 医学
小类 | 3 区 神经科学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 神经科学
JCR分区:
出版当年[2013]版:
Q2 NEUROSCIENCES
最新[2023]版:
Q4 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [1]Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Beijing Institute for Brain Disorders, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing, China
共同第一作者:
通讯作者:
通讯机构: [*1]Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Beijing Institute for Brain Disorders, 45 Chang-chun Street, Beijing 100053, China. [*2]Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, 45 Changchun Street, Beijing 100053, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院